EUVIMEDEUVIMED entdecken
Crossref

Non-alcoholic fatty liver disease as a leading metabolic risk factor for severe COVID-19: a gender analysis

M. M. Abdurakhmаnov, H. D. Tagaeva, A. R. Oblokulov, K. A. Umedov, Z. M. Abdurakhmanov

Perm Medical Journal · 10.07.2026 · 43 (3) · 50-58

DOI: 10.17816/pmj43350-58 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Perm Medical Journal, online erschienen am 10.07.2026. Verfasst von M. M. Abdurakhmаnov und 4 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the sex-related association between non-alcoholic fatty liver disease (NAFLD) and COVID-19 severity, and to assess the impact of metabolic syndrome components on the risk of severe disease. Materials and methods. A retrospective analysis was conducted on 105 patients hospitalized with COVID-19 at the Bukhara Regional Infectious Diseases Hospital between September 2020 and September 2022. The diagnosis of non-alcoholic fatty liver disease (NAFLD) was established based on computed tomography (CT) or medical history. The study group included 55 patients with COVID-19 and NAFLD, while 50 patients with COVID-19 without NAFLD served as the control group. Multivariate logistic regression analysis was performed to evaluate predictors of severe COVID-19, adjusting for age, sex, body mass index (BMI), smoking, and components of metabolic syndrome.

Results

Severe COVID-19 occurred significantly more often in patients with NAFLD compared to those without NAFLD (34.5 vs. 18.0 %; p = 0.001). NAFLD and smoking were identified as the strongest independent predictors of severe disease. Women with NAFLD exhibited a higher risk of severe COVID-19 (odds ratio (OR) 4.17; 95 % CI 4.08–4.58; p = 0.001) compared to men (OR 3.18; 95 % CI 3.10–3.69; p = 0.004), whereas type 2 diabetes mellitus (T2DM) had minimal impact on this risk in women compared to men (OR 0.95; 95 % CI 0.84–1.09; p = 0.04). Obesity and metabolic syndrome were also independent predictors of severe disease in both sexes.

Conclusions

NAFLD is an independent risk factor for severe COVID-19 in both sexes, with a more pronounced risk in women. These findings underscore the importance of a comprehensive management approach for patients with COVID-19 that considers underlying NAFLD and metabolic abnormalities. Further large-scale prospective studies are needed to clarify the mechanisms underlying this association.

Zitieren

APA

Abdurakhmаnov, M. M., Tagaeva, H. D., Oblokulov, A. R., Umedov, K. A., & Abdurakhmanov, Z. M. (2026). Non-alcoholic fatty liver disease as a leading metabolic risk factor for severe COVID-19: a gender analysis. Perm Medical Journal, 43(3), 50-58. https://doi.org/10.17816/pmj43350-58

Vancouver

Abdurakhmаnov MM, Tagaeva HD, Oblokulov AR, Umedov KA, Abdurakhmanov ZM. Non-alcoholic fatty liver disease as a leading metabolic risk factor for severe COVID-19: a gender analysis. Perm Medical Journal. 2026;43(3):50-58. doi:10.17816/pmj43350-58

BibTeX
@article{Abdurakhmnov2026,
  author = {Abdurakhmаnov, M. M. and Tagaeva, H. D. and Oblokulov, A. R. and Umedov, K. A. and Abdurakhmanov, Z. M.},
  title = {Non-alcoholic fatty liver disease as a leading metabolic risk factor for severe COVID-19: a gender analysis},
  journal = {Perm Medical Journal},
  year = {2026},
  volume = {43},
  number = {3},
  pages = {50--58},
  doi = {10.17816/pmj43350-58}
}
Kostenlos starten →